← back to search

Jeffrey P. Krischer

University of South Florida · US
🔎 Find collaborators in Genetics · Surgery →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Genetics · Surgery
Research interest
Research interests include Diabetes and associated disorders, Pancreatic function and diabetes, Diabetes Management and Research, and Celiac Disease Research and Management.
h-index
104
citations
38,173
works
618
NIH funding
primary concept
Medicine
email

Recent publications

Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes.
2026cited by 2position: contributordoi
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.
2026cited by 1position: contributordoi
Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity.
2026cited by 0position: contributordoi
Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study.
2026cited by 0position: contributordoi
A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis
Arthritis & Rheumatology 2025cited by 8position: middledoi
Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives.
2025cited by 7position: contributordoi
Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter.
2025cited by 7position: contributordoi
Unfolding the Mystery of Autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) Study
Diabetes Care 2025cited by 7position: middledoi
Comparative Analysis of the Sensitivity, Specificity, Concordance, and 5-Year Predictive Power of Diabetes-Related Autoantibody Assays.
2025cited by 2position: contributordoi
Caesarean section and risk of type 1 diabetes.
2024cited by 7position: contributordoi
Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes
Diabetologia 2024cited by 7position: middledoi
Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis.
2024cited by 6position: contributordoi
The Influence of Pubertal Development on Autoantibody Appearance and Progression to Type 1 Diabetes in the TEDDY Study.
2024cited by 3position: contributordoi
Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes.
2024cited by 0position: contributordoi
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial
˜The œLancet. Gastroenterology & hepatology 2023cited by 143position: middledoi
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial
Diabetes Care 2023cited by 96position: middledoi
Physical Activity and the Development of Islet Autoimmunity and Type 1 Diabetes in 5- to 15-Year-Old Children Followed in the TEDDY Study
Diabetes Care 2023cited by 26position: middledoi
Physical Activity and the Development of Islet Autoimmunity and Type 1 Diabetes in 5- to 15-Year-Old Children Followed in the TEDDY Study.
2023cited by 21position: contributordoi
Hydroxychloroquine in Stage 1 Type 1 Diabetes
Diabetes Care 2023cited by 16position: middledoi
The Rare and Atypical Diabetes Network (RADIANT) Study: Design and Early Results
Diabetes Care 2023cited by 14position: contributordoi
Data Mining Framework for Discovering and Clustering Phenotypes of Atypical Diabetes.
2023cited by 8position: contributordoi
Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis Study.
2023cited by 6position: contributordoi
Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study.
2022cited by 66position: contributordoi
Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study
Gastroenterology 2022cited by 49position: middledoi
Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study
Scientific Reports 2022cited by 15position: middledoi
Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis Study (Preprint)
2022cited by 1position: contributordoi
Author Correction: A combined risk score enhances prediction of type 1 diabetes among susceptible children
Nature Medicine 2022cited by 1position: middledoi
Additional file 2 of A robust and transformation-free joint model with matching and regularization for metagenomic trajectory and disease onset
Open MIND 2022cited by 0position: lastdoi
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet Diabetes & Endocrinology 2021cited by 131position: middledoi
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk
Gastroenterology 2021cited by 50position: middledoi

Grants

Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-04S9$2,583,3352025–2026Contact PIRePORTER
The Florida Pediatric NCORP: NCI Community Oncology Research Program.
NIH3UG1CA189973-11S1$683,2972025–2026PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-03S1$492,0002024–2025Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH1U01DK128847-01$28,378,7812021–2025Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH5U01DK128847-02$15,320,3722021–2025Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH5U01DK128847-03$13,869,9312021–2025Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH5U01DK128847-04$11,681,5402021–2026Contact PIRePORTER
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
NIH4R33HL156888-03$2,132,0042021–2026PIRePORTER
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
NIH5R33HL156888-04$1,817,2872021–2026PIRePORTER
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
NIH5R33HL156888-05$1,112,2962021–2027PIRePORTER
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
NIH1R61HL156888-01$410,6072021–2023PIRePORTER
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
NIH5R61HL156888-02$389,2252021–2023PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-04S3$308,0852021–2026Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-04S6$135,4232021–2026Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-04S8$83,2802021–2026Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-04S5$77,4642021–2026Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-04S7$66,1912021–2026Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-04S2$34,6002021–2026Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-04S1$24,2342021–2026Contact PIRePORTER
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK128847-04S4$3,9662021–2026Contact PIRePORTER
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH1U01DK124166-01$9,999,9392020–2023Contact PIRePORTER
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH5U01DK124166-02$9,999,8612020–2023Contact PIRePORTER
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH5U01DK124166-03$9,999,8602020–2024Contact PIRePORTER
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
NIH3U01DK124166-01S1$1,124,8362020–2023Contact PIRePORTER
RARE and Atypical Diabetes Network(RADIANT)
NIH5U54DK118638-07$2,500,0002018–2029PIRePORTER

Frequent collaborators

· 24 papers (2019–2026)Jay S. Skyler · University of Miami16 papers (2012–2023)Åke Lernmark · Centralsjukhuset Kristianstad14 papers (2015–2026)Jay M. Sosenko · University of Miami14 papers (2012–2024)Beena Akolkar · National Institutes of Health13 papers (2015–2026)Jorma Toppari · University of Turku13 papers (2015–2026)Andrea K. Steck · St Thomas' Hospital12 papers (2016–2026)Carla J. Greenbaum · Center for Infectious Disease Research12 papers (2012–2023)Desmond Schatz · University of Florida Health11 papers (2013–2024)Kevan C. Herold · Yale New Haven Hospital10 papers (2013–2024)Jin‐Xiong She · China Three Gorges University9 papers (2015–2026)Kendra Vehik · University of South Florida9 papers (2017–2026)David Boulware · Aurora St. Luke's Medical Center8 papers (2012–2019)Anette-G. Ziegler · Wellcome Trust8 papers (2019–2026)Jerry P. Palmer · University of Washington8 papers (2012–2018)William Hagopian · Indiana University Health8 papers (2015–2021)David Cuthbertson · McMaster University8 papers (2012–2024)Kalle Kurppa · Seinäjoen Keskussairaala8 papers (2017–2023)Craig A. Beam · University of Illinois Chicago8 papers (2012–2015)Peter A. Gottlieb · Chinese University of Hong Kong8 papers (2013–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Genetics · Surgery →